Table 1.
ID | Sex |
GTPBP3 Mutations |
OXPHOS Activities in Skeletal Muscle |
Clinical Features |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
cDNA (NM_032620.3) and Protein (NP_116009.2) | RCC | % of Lower Control Range | Absolute Values | Reference Range | AO | Course | HCM | Histochemical COX Defect | Other Features | ||
#49665a,b | male | c.[1291dupC; 1375G>A], p.[Pro430Argfs∗86; Glu459Lys] | I | 15% | 0.025 | 0.17–0.56 | 10 years | alive 14 years | yes | ND | consanguineous parents (1st cousins), mild intellectual disability, fatigability, limited vision, lactic acidosis |
II | ND | ND | ND | ||||||||
II+III | normal | 0.201 | 0.08–0.48 | ||||||||
IV | 24% | 0.267 | 1.1–5.0 | ||||||||
#36349b | male | c.[1291dupC; 1375G>A], p.[Pro430Argfs∗86; Glu459Lys] | I | no data | no data | no data | no data | alive 17 years | no data | no data | sibling of #49665 with similar clinical symptoms |
II | |||||||||||
II+III | |||||||||||
IV | |||||||||||
#66143a | male | c.[476A>T; 964G>C], p.[Glu159Val; Ala322Pro] | I | 7% | 0.01 | 0.19–0.48 | 2 years | alive 5 y ears | yes | ND | unrelated parents, sudden respiratory failure, lactic acidosis |
II | normal | 0.10 | 0.07–0.12 | ||||||||
II+III | normal | 0.12 | 0.09–0.22 | ||||||||
IV | 28% | 0.12 | 0.44–0.92 | ||||||||
#72425a | female | c.[484G>C; 673G>A; 964G>C], p.[Ala162Pro; Glu225Lys; Ala322Pro] | I | 14% | 0.015 | 0.11–0.30 | 3.5 months | died 8 months | DCM | yes | unrelated parents, cyanosis, hyporeactivity, DCM with residual ejection fraction of 20%, lactic acidosis |
II | normal | 0.21 | 0.12–0.25 | ||||||||
II+III | normal | 0.06 | 0.006–0.14 | ||||||||
IV | 45% | 0.76 | 1.7–4.0 | ||||||||
#75191a | female | c.[1009G>C; 1009G>C], p.[Asp337His; Asp337His] | I | 31% | 0.03 | 0.10–0.25 | birth | died 1 day | yes | yes | unrelated parents, Kussmaul breathing, stridor, hypotonic, hyporeactivity, RVH, lactid acidosis |
II | normal | 0.16 | 0.14–0.25 | ||||||||
II+III | normal | 0.12 | 0.13–0.25 | ||||||||
IV | 15% | 0.09 | 0.60–1.48 | ||||||||
#76671 | male | c.[665−2delA; 665−2delA], p.[Ala222Gly; Asp223_Ser270del; Ala222Gly; Asp223_Ser270del] | I | 45% | 0.05 | 0.11–0.30 | birth | died 10 months | yes | yes | unrelated parents, hypotonia from birth, RVH, WPW, lactic acidosis |
II | normal | 0.16 | 0.12–0.25 | ||||||||
II+III | ND | ND | 0.06–0.14 | ||||||||
IV | 17% | 0.29 | 1.7–4.0 | ||||||||
#81471a | male | c.[424G>A; 424G>A], p.[Glu142Lys; Glu142Lys] | I | 12% | 0.012 | 0.104 ± 0.036 | 4 weeks | died 5 weeks | yes | yes | consanguineous parents, two healthy siblings, one miscarriage, FTT, poor weight gain and feeding, concentric LVH, lactic acidosis |
II | normal | 0.098 | 0.145 ± 0.047 | ||||||||
II+III | normal | 0.850 | 0.544 ± 0.345 | ||||||||
IV | 17% | 0.127 | 1.124 ± 0.511 | ||||||||
#75168a | female | c.[770C>A; 770C>A], p.[Pro257His; Pro257His] | I | normal | no data | no data | 2 years | alive 5 years | no | ND | consanguineous parents (1st cousins), developmental delay, epileptic seizures, intellectual disability, MRI hyperintense lesions of basal ganglia typical to Leigh syndrome, lactic acidosis |
II | normal | ||||||||||
II+III | normal | ||||||||||
IV | normal | ||||||||||
#82790a | female | c.[8G>T; 934_957del], p.[Arg3Leu; Gly312_Val319del] | I | 36% | 0.107 | 0.301 ± 0.05 | 1 year | alive 2 years | no | ND | unrelated parents, seizures, severe hypotonia, developmental delay, lactic acidosis |
II | normal | 0.424 | 0.272 ± 0.05 | ||||||||
II+III | normal | 0.21 | 0.25 ± 0.093 | ||||||||
IV | 21% | 0.008 | 0.035 ± 0.011 | ||||||||
#83904a,c | female | c.[32_33delinsGTG; 32_33delinsGTG], p.[Gln11Argfs∗98; Gln11Argfs∗98] | I | 64% | 4.2 | 6.5–17 | 1 week | died 9 months | yes | ND | consanguineous parents (1st cousins), lactic acidosis, WPW |
II | normal | 16.1 | 13.6–45.7 | ||||||||
II+III | normal | 5.8 | 4.3–13.2 | ||||||||
IV | 25% | 9.9 | 74–294 | ||||||||
#83905a,c | female | c.[32_33delinsGTG; 32_33delinsGTG], p.[Gln11Argfs∗98; Gln11Argfs∗98] | I | no data | no data | no data | birth | died 10 days | yes | ND | consanguineous parents (1st cousins), lactic acidosis, WPW |
II | |||||||||||
II+III | |||||||||||
IV | |||||||||||
#66654a | female | c.[673G>A; 964G>A]; [=] p.[Glu255Lys; Ala322Pro]; [=] | I | 64% | 0.09 | 0.14–0.35 | 1.5 months | alive | no | ND | intrauterine growth retardation, lactic acidosis, leukodystrophy, generalized hypotonia |
II | normal | 0.19 | 0.18–0.41 | ||||||||
II+III | 90% | 0.27 | 0.30–0.67 | ||||||||
IV | normal | 1.42 | 0.42–1.26 |
Abbreviations are as follows: AO, age of onset; HCM, hypertrophic cardiomyopathy; DCM, dilated cardiomyopathy; FTT, failure to thrive; LVH/RVH, left/right ventricular hypertrophy; ND, not determined; WPW, Wolff-Parkinson-White syndrome.
Mitochondrial respiratory chain complexes (RCC) in muscle: I, NADH:CoQ-oxidoreductase; II, succinate:CoQ-oxidoreductase; II+III, succinate:cytochrome c reductase; IV, cytochrome c oxidase (COX).
Enzyme activities were determined in muscle biopsies and normalized to citrate synthase (CS). Absolute values and reference ranges are given in [mU / mU CS].
Investigated by exome sequencing.
These individuals are siblings.